CVT 0.00% $1.22 comvita limited ordinary shares

Ann: OFFICE: CVT: Comvita outlines leadership team changes

  1. lightbulb Created with Sketch. 2
    • Release Date: 16/03/16 10:36
    • Summary: OFFICE: CVT: Comvita outlines leadership team changes
    • Price Sensitive: No
    • Download Document  3.6KB
    					CVT
    16/03/2016 10:36
    OFFICE
    NOT PRICE SENSITIVE
    REL: 1036 HRS Comvita Limited
    
    OFFICE: CVT: Comvita outlines leadership team changes
    
    Global natural health products company Comvita (NZX: CVT) has recently
    appointed key executive personnel to strengthen the company's growth
    platform, and position it for the next phase of development. It also
    farewells Chief Sales and Marketing Officer Roy Ong and advises a change in
    role for Dr. Ralf Schlothauer.
    
    Key Appointments:
    o  Mr Colin Baskin as Chief Supply Chain Officer (CSCO) to deliver supply
    efficiencies and enhance supply partnerships.
    o  Ms Sharon Hollenstein as Chief Innovation Officer (CINO) to drive product
    innovation using our core ingredient platforms.
    
    These two roles expand the current Leadership Team, which comprises:
    o  Scott Coulter, Chief Executive Officer
    o  Mark Sadd, Chief Financial Officer
    o  Patrick Brus, Chief Corporate Services Officer
    
    Comvita CEO Scott Coulter said, "This new executive structure is in keeping
    with the growth and complexity of Comvita and will meet the wider needs of
    the business, including our increased strategic focus on product innovation
    using our core ingredient platforms, Manuka honey, Propolis, Olive Leaf and
    our new investment in Omega 3 fish oil."
    
    "Dr. Ralf Schlothauer, who was our Chief Technology Officer, will now act in
    a formal consultancy role to the company, outside of the leadership team.
    
    Background information on the new appointments follows:
    
    Chief Supply Chain Officer (CSCO), Colin Baskin; DipT, MBA (Distinction)
    Colin Baskin is appointed to the newly created role of Chief Supply Chain
    Officer, reflecting the importance of supply chain to Comvita. Colin has an
    international career in supply chain within the Primary Sector and joined
    Comvita in 2007 from ZESPRI International Ltd, where he was Global Supply
    Manager. In 2014, as General Manager Supply Chain, Colin personally received
    the Bay of Plenty Tertiary Partnership Export Achievement Award and in May
    2015 the Comvita supply chain was awarded the NZ China Trade Association
    (NZCTA) award for supply chain innovation. As CSCO, Colin has responsibility
    for Comvita's global supply network including our Olive Leaf operation in
    Australia and the Kiwi Bee Apiary operations. Leading a large team, Colin's
    focus is on delivering supply efficiencies and enhancing our supply
    partnerships.
    
    Chief Innovation Officer (CINO), Sharon Hollenstein; B.Sc, (1st Class Hons,
    Chem); PhD, Bio-Organic Chem.
    Sharon Hollenstein will join Comvita on 11th of April 2016 from Fonterra,
    where she has spent over 10 years in a number of high level innovation and
    new product development roles; most recently in the position of Global
    Manager Innovation - Anlene. In this role, Sharon was responsible for
    delivering innovation initiatives that would deliver significant value
    growth. Sharon also comes to us with relevant global market experience having
    been based in Malaysia for two and a half years, and also holding key
    positions within Fonterra that focused on the China, Asia, Europe and North
    American markets.  Sharon has an exceptional combination of innovation
    experience within a global FMCG business, and will be a true asset to the
    Comvita team.
    
    Ends
    
    For further information:
    Scott Coulter, Comvita CEO, 021 386 988
    Neil Craig, Comvita Chairman, 021 731 509
    Julie Chadwick, Comvita Communications Manager, 021 510 693
    
    Background information
    About Comvita (www.comvita.com)
    Comvita (NZX:CVT) is a global natural health company committed to the
    development of innovative products, backed by ongoing investment in
    scientific research.
    End CA:00279346 For:CVT    Type:OFFICE     Time:2016-03-16 10:36:07
    				
 
watchlist Created with Sketch. Add CVT (NZSX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.